| Ainsworth Game Technology Limited (AGI) ORDINARY FULLY PAID |
Consumer Discretionary |
$354 |
2025 AGM Addresses to Shareholders and Presentation
|
28 May 2025 9:54AM |
$0.920 |
$1.050 |
risen by
14.13%
|
|
| Ambertech Limited (AMO) ORDINARY FULLY PAID |
Information Technology |
$14 |
Change of Director's Interest Notice
|
28 May 2025 9:54AM |
$0.155 |
$0.150 |
fallen by
3.23%
|
|
| Talga Group Ltd (TLG) ORDINARY FULLY PAID |
Materials |
$191 |
Prospectus
|
28 May 2025 9:54AM |
$0.415 |
$0.375 |
fallen by
9.64%
|
|
| Nido Education Limited (NDO) ORDINARY FULLY PAID |
Consumer Discretionary |
$108 |
Notification of cessation of securities - NDO
|
28 May 2025 9:52AM |
$0.760 |
$0.475 |
fallen by
37.50%
|
|
| High-Tech Metals Limited (HTM) ORDINARY FULLY PAID |
Materials |
$29 |
Application for quotation of securities - HTM
|
28 May 2025 9:50AM |
$0.165 |
$0.280 |
risen by
69.70%
|
|
| Acorn Capital Investment Fund Limited (ACQ) ORDINARY FULLY PAID |
Financials |
$89 |
Application for quotation of securities - ACQ
|
28 May 2025 9:49AM |
$0.740 |
$0.990 |
risen by
33.78%
|
|
| Koonenberry gold Limited (KNB) ORDINARY FULLY PAID |
Materials |
$29 |
Cleansing Notice
|
28 May 2025 9:46AM |
$0.066 |
$0.028 |
fallen by
57.58%
|
|
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$16 |
ReNerve receives market approval in Bahrain
|
28 May 2025 9:46AM |
$0.105 |
$0.120 |
risen by
14.29%
|
|
RNV - Price-sensitive ASX Announcement
Full Release
Key Points
- ReNerve Limited received market approval in Bahrain for the Nerve Repair Conduit (NRC).
- The NRC is used to repair and regenerate peripheral nerves after injury.
- This is ReNerve’s first regulatory clearance in the Middle East.
- The product is already approved in Australia and New Zealand.
- ReNerve is pursuing regulatory processes in other territories.
- Approval in Bahrain enables potential access to regional markets.
- ReNerve plans to partner with local distributors for market entry.
- The NRC addresses a key unmet clinical need in nerve injury treatment.
- The approval supports ReNerve’s international commercialization strategy.
- The company is focused on expanding its global presence in regenerative medicine.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Switzer Dividend Growth Fund (Managed Fund) (SWTZ) |
Financials |
$59 |
Distribution for month ending 31 May 2025
|
28 May 2025 9:43AM |
$2.400 |
$2.490 |
risen by
3.75%
|
|
| Perpetual Resources Limited (PEC) ORDINARY FULLY PAID |
Materials |
$12 |
Lithium Soil Anomaly Extends Over 1.4km at Igrejinha
|
28 May 2025 9:42AM |
$0.013 |
$0.013 |
fallen by
0%
|
|
PEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Perpetual Resources Limited reported a lithium-in-soil anomaly at the Igrejinha Project in Brazil now extends over 1.4 kilometers.
- Soil sampling revealed high lithium values and supportive pathfinder elements such as cesium, tantalum, and rubidium.
- Ongoing exploration includes further geochemical sampling, mapping, and planned drilling to advance the project.
- The anomaly’s scale and strength indicate significant mineralization potential.
- The geological context and results compare favorably with other well-known lithium projects.
- The Igrejinha Project’s development is aligned with the growing demand for lithium globally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$46 |
Suspension from Quotation
|
28 May 2025 9:42AM |
$0.440 |
$0.330 |
fallen by
25%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ Ltd (ASX: IIQ) securities suspended from quotation by the ASX
- Suspension effective from the commencement of trading on 13 June 2024
- Suspension due to pending announcement of a material corporate transaction
- Securities will remain suspended until the announcement is released
- Procedures and implications of the suspension detailed in the announcement
- Contact details provided for further information or inquiries
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Epsilon Healthcare Limited (EPN) ORDINARY FULLY PAID |
Health Care |
$12 |
CEO AGM Update
|
28 May 2025 9:41AM |
$0.024 |
$0.030 |
risen by
25%
|
|
EPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Epsilon Healthcare exited administration on June 24, 2024.
- Focus on stabilizing company operations and rebuilding trust.
- Expansion of Epsilon Pharma and Epsilon Clinics subsidiaries.
- Launch of Epsilon Pharmacy as part of a new 'one brand' strategy.
- Initiatives in digital health and strategic partnerships.
- Commitment to medicinal cannabis and plant-based therapies.
- Emphasis on sustainable long-term growth and operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Western Gold Resources Limited (WGR) ORDINARY FULLY PAID |
Materials |
$56 |
Agreement of shareholders regarding proposed sale of shares
|
28 May 2025 9:38AM |
$0.063 |
$0.190 |
risen by
201.59%
|
|
WGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Western Gold Resources Limited has entered into an agreement involving certain shareholders for the proposed sale of shares.
- The agreement specifies the terms and conditions under which the shares will be transferred.
- Key shareholders and the number of shares subject to the agreement are identified in the document.
- Completion of the transaction is subject to satisfaction of conditions precedent, including necessary regulatory and third-party approvals.
- The proposed sale does not amount to a formal takeover bid under current regulations.
- The company will remain compliant with its continuous disclosure obligations.
- Western Gold Resources Limited will provide further announcements if there are material developments relating to the agreement or the proposed sale of shares.
- The announcement reaffirms that there is no immediate change in control or management of the company as a result of this agreement.
- The transaction is expected to have an impact on the company's shareholder structure pending completion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$46 |
Response to ASX Price Query
|
28 May 2025 9:38AM |
$0.440 |
$0.330 |
fallen by
25%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ Ltd received an ASX Price Query regarding unusual share price and trading volume movement.
- The company is not aware of any unannounced information that could explain the trading activity.
- INOVIQ Ltd states that it is in compliance with ASX Listing Rule 3.1 and disclosure obligations.
- There are no material changes or pending announcements that could account for the share price movement.
- The company has made all necessary disclosures to the market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$151 |
Issue of Shares and Cleansing Notice
|
28 May 2025 9:38AM |
$0.230 |
$0.740 |
risen by
221.74%
|
|
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$2,332 |
Argo and Bokoro Exploration Permits Update
|
28 May 2025 9:37AM |
$0.435 |
$0.885 |
risen by
103.45%
|
|
PDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Predictive Discovery Ltd updated on the status of Argo and Bokoro Exploration Permits in Guinea.
- Renewal applications for both permits have been submitted in accordance with the Guinean Mining Code.
- Both permits are in good standing while the renewal process is ongoing.
- PDI is maintaining ongoing communication with Guinean authorities regarding permit renewals.
- The Argo and Bokoro permits are crucial to the Bankan Gold Project.
- Bankan Project remains a top priority for Predictive Discovery Ltd.
- Exploration and development activities will continue as planned, subject to permit renewals.
- No adverse actions from the Guinean government have been reported regarding the permit status.
- PDI will provide further updates as and when material information becomes available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Capital International Fund (Hedged) Active ETF (L1HI) |
Financials |
$26 |
Quarterly Portfolio Disclosure - March 2025
|
28 May 2025 9:36AM |
$5.560 |
$5.580 |
risen by
0.36%
|
|
| Australian Vintage Ltd (AVG) ORDINARY FULLY PAID |
Consumer Staple |
$30 |
Change of Director's Interest Notice (James Williamson)
|
28 May 2025 9:36AM |
$0.075 |
$0.092 |
risen by
22.67%
|
|
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
Trading Halt
|
28 May 2025 9:36AM |
$0.050 |
$0.036 |
fallen by
28%
|
|
CDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Cardiex Limited (CDX) requested a trading halt on 7 June 2024.
- The trading halt is pending an announcement regarding material capital raising.
- The halt is to ensure the orderly management of the capital raising and market operations.
- The trading halt will remain in place until the capital raising announcement or until trading resumes on 11 June 2024.
- The request for the trading halt was made to the Australian Securities Exchange (ASX).
- Cardiex confirmed that there is no reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Koonenberry gold Limited (KNB) ORDINARY FULLY PAID |
Materials |
$29 |
Application for quotation of securities - KNB
|
28 May 2025 9:36AM |
$0.066 |
$0.028 |
fallen by
57.58%
|
|
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$151 |
Application for quotation of securities - MM1
|
28 May 2025 9:36AM |
$0.230 |
$0.740 |
risen by
221.74%
|
|
| GDI Property Group (GDI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$316 |
Bell Potter conference presentation
|
28 May 2025 9:34AM |
$0.695 |
$0.585 |
fallen by
15.83%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$82 |
Letter to Imugene Shareholders
|
28 May 2025 9:33AM |
$0.017 |
$0.255 |
risen by
1,400%
|
|
| RAS Technology Holdings Limited (RTH) ORDINARY FULLY PAID |
Industrials |
$38 |
RAS Technology delivers strong ARR growth
|
28 May 2025 9:33AM |
$0.830 |
$0.800 |
fallen by
3.61%
|
|
RTH - Price-sensitive ASX Announcement
Full Release
Key Points
- RAS Technology Holdings Limited reported strong ARR growth of 39% to $18.6 million for H1 FY24.
- Total revenue grew by 31% to $23.7 million year-on-year.
- Racing and Sports B2B wagering technology business drove significant growth.
- New product launches and expanded partnerships contributed to performance.
- Geographic expansion, especially in North America, was a key growth driver.
- Disciplined cost management led to improved EBITDA and reduced statutory net loss.
- The company remains focused on innovation, operational efficiency, and international growth.
- RTH expects continued ARR and revenue momentum in the second half of FY24.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Capital International Fund (Managed Fund) (L1IF) |
Financials |
$441 |
Quarterly Portfolio Disclosure - March 2025
|
28 May 2025 9:33AM |
$6.650 |
$6.030 |
fallen by
9.32%
|
|